Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical 
Thioacetic Acid Addition

ABSTRACT: BACKGROUND: In the expanding field of anticancer drugs, HDAC inhibitors are playing an increasingly important role. To date, four/five HDAC inhibitors have been approved by FDA. All these compounds fit the widely accepted HDAC inhibitors pharmacophore model characterized by a cap group, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Battistuzzi, Gianfranco, Giannini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101637/
https://www.ncbi.nlm.nih.gov/pubmed/27917100
http://dx.doi.org/10.2174/1573407212666160504160556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101637/
https://www.ncbi.nlm.nih.gov/pubmed/27917100
http://dx.doi.org/10.2174/1573407212666160504160556

Ejemplares similares